
CAS Name: N-[(4-Amino-2-methyl-5-pyrimidinyl)methyl]-N-[1-(2-oxo-1,3-oxathian-4-ylidene)ethyl]formamide
Additional Names: carbothiamine; cyclocarbothiamine; cycotiamine; CCT
Trademarks: Come...
Literature References: Prepn: NL 6511842 corresp. to Murakami et al., US 3324124 (1966, 1967 to Yamanouchi Seiyaku).
CAS Name: N-(1-Methylethyl)-4,4-diphenylcyclohexanamine
Additional Names: N-isopropyl-4,4-diphenylcyclohexylamine; pramiverine; primaverine; propaminodiphen
Percent Composition: C 85.95%, H ...
Literature References: Prepn: NL 6515046; R. Unger et al., US 3376312 (1966, 1968 both to E. Merck). Pharmacology: H. J. Enenkel et al., Arzneim.-Forsch. 26, 690 (1976). Toxicological study: M. Von Eberstein et al., ibid., 703. Series of articles on pharmacology, pharmacokinetics, GC determn, clinical studies: ibid., 686-752. Use in management of labor: G. LoDico et al., Minerva Ginecol. 31, 683 (1979).
CAS Name: 3-[Acetyl-(3-amino-2,4,6-triiodophenyl)amino]-2-methylpropanoic acid
Additional Names: N-acetyl-N-(3-amino-2,4,6-triiodophenyl)-2-methyl-b-alanine; N-acetyl-N-(2,4,6-triiodo-3-aminoph...
Literature References: Prepn: NL 6515305; NL 6607275 (both 1967 to Dagra), C.A. 67, 108422m (1967); 69, 10263b (1968); Korver, Rec. Trav. Chim. 87, 308 (1968). Pharmacology and toxicology: J. M. Janbroers et al., Toxicol. Appl. Pharmacol. 14, 232, 246 (1969). Metabolic studies: Neleman, Pharm. Weekbl. 102, 1039 (1967). Clinical studies: Hekster, Radiol. Clin. Biol. 37, 338 (1968). Use in cholecystography: B. Goldberg, Radiol. Clin. 46, 42 (1977).
CAS Name: 4-Hydroxy-3-iodo-5-nitrobenzonitrile
Trademarks: Dovenix (Specia)
Percent Composition: C 28.99%, H 1.04%, I 43.76%, N 9.66%, O 16.55%
Literature References: Prepn: NL 6516359 corresp to Collins et al., US 3331738 (1966, 1967 both to May Baker).
CAS Name: 17-Methyl-19-norpregna-4,9-diene-3,20-dione
Additional Names: 17a-methyl-19-nor-D4,9-pregnadiene-3,20-dione; 17a-methyl-D9-19-norprogesteroneTrademarks: Lutionex (Roussel Diamant)
...
Literature References: Prepn: NL 6517141; R. Joly et al., US 3547959 (1966, 1970 both to Roussel-UCLAF); L. Velluz et al., Tetrahedron Suppl. 8, part II, 495 (1966); R. Joly et al., Bull. Soc. Chim. Fr. 1973, 2694.
CAS Name: 2-(4-Chlorophenoxy)-2-methylpropanoic acid 1,3-propanediyl ester
Additional Names: 2-(p-chlorophenoxy)-2-methylpropionic acid trimethylene ester; 1,3-propanediol bis[a-(p-chlorophenox...
Literature References: Prepn: NL 6600044 corresp to Nakanishi et al., US 3494957 (1966, 1970 to Yoshitomi). Activity and toxicology studies: Nakanishi et al., J. Pharm. Soc. Jpn. 90, 267, 921, 926 (1970). Activity on postheparin lipoprotein lipase: L. Cavallini et al., Clin. Ter. 92, 25 (1980).
CAS Name: 6-[2-(Dimethylamino)propyl]-1,6-dihydro-5H-pyrido[2,3-b][1,5]benzodiazepin-5-one
Additional Names: 6,11-dihydro-6-[2-(dimethylamino)-2-methylethyl]-5H-pyrido[2,3-b][1,5]benzodiazepin-...
Literature References: Prepn: NL 6600065 (1966 to Labs. U.P.S.A.); Hoffmann, Faure, Bull. Soc. Chim. Fr. 1966, 2316. Psychopharmacology: Lwoff et al., Therapie 26, 451 (1971).
CAS Name: 3,7-Dihydro-1,3-dimethyl-7-[2-[(3-pyridinylmethyl)amino]ethyl]-1H-purine-2,6-dione
Additional Names: 7-[2-[(3-pyridylmethyl)amino]ethyl]theophylline; 7-(b-3'-picolylaminoethyl)theophy...
Literature References: Prepn: NL 6600250; Suter, Zutter, US 3350400 (1966, 1967 both to Eprova). Structure determn, properties and chemistry: eidem, Pharm. Acta Helv. 48, 133 (1973). Pharmacology: Ciaceri, Attaguile, Gazz. Med. Ital. 132, 36, 108 (1973). Metabolism: Pitrè, Farmaco Ed. Prat. 29, 46 (1974).
CAS Name: 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid
Additional Names: [o-(2,6-dichloroanilino)phenyl]acetic acid
Trademarks: Motifene (Sankyo)
Percent Composition: C 56.78%, H 3.74%...
Literature References: Prepn: NL 6604752; A. Sallmann, R. Pfister, US 3558690 (1966, 1971 both to Geigy). Pharmacology: Renaud, Lecompte, Thromb. Diath. Haemorrh. 24, 577 (1970), C.A. 74, 86215m (1971); Krupp et al., Experientia 29, 450 (1973). HPLC determn in plasma and urine: J. Godbillon et al., J. Chromatogr. 338, 151 (1985). Symposium on pharmacology and clinical experience: Semin. Arthritis Rheum. 15, Suppl. 1, 57-110 (1985); on pharmacology, efficacy and safety: Am. J. Med. 80, Suppl. 4B, 1-87 (1986). Comprehensive description: C. M. Adeyeye, P-K. Li, Anal. Profiles Drug Subs. 19, 123-144 (1990). Review of clinical trials in actinic keratosis: D. C. Peters, R. H. Foster, Drugs Aging 14, 313-319 (1999).
CAS Name: 4-(Decyloxy)-3,5-dimethoxybenzamideTrademarks: Denegyt
Percent Composition: C 67.63%, H 9.26%, N 4.15%, O 18.97%
Literature References: Prepn: NL 6605460; E. Kasztreiner et al., US 3432549 (1966, 1969 both to EGYT). Pharmacology: E. Kasztreiner, Magy. Kem. Lapja 27, 370 (1972), C.A. 78, 66697z (1973); I. Kiraly et al., Acta Physiol. Acad. Sci. Hung. 47, 200 (1976). Metabolism study: G. Molnar et al., Acta Pharm. Hung. 48, Suppl., 58 (1978). Toxicity data: E. Usdin, D. H. Efron, Eds., Psychotropic Drugs and Related Compounds (NIH, Washington, D. C., 2nd Ed., 1972) p 377.
即日起可免费注册成为会员, 建立企业产品库, 免费上传产品目录, 企业介绍等. 让你的产品直接呈现给客户.
试运营阶段,所有广告业务5折优惠
